Proteus Digital Health Inc. announced today that it joined forces with Minneapolis-based Fairview Health Services and the University of Minnesota Health to prescribe "digital capecitabine," encapsulating the common chemotherapy drug with Proteus' sensor, to colorectal cancer patients. The goal is to improve treatment and outcomes through home-based remote monitoring.
George Savage, co-founder and chief medical officer at Proteus, said the digital therapy can help cancer patients complete the recommended full eight cycles of chemotherapy, which is challenging for many...